drug metabolism

23andMe Granted The First and Only FDA Authorization For Direct-to-Consumer Pharmacogenetics Reports

October 31, 2018
The U.S. Food and Drug Administration (FDA) granted 23andMe authorization to offer reports to customers on pharmacogenetics, indicating how customers’ genetics may influence the way they metabolize certain medications.
Read More

The Rest of the Iceberg

August 19, 2008
In a recent post we used an analysis of Craig Venter’s genome to illustrate how much has yet to be learned about the relationship between genetic variation and health-related traits....
Read More